Pfm Health Sciences, LP Vectiv Bio Holding Ag Transaction History

Pfm Health Sciences, LP

$1.71 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 15, 2023	BUY	$7.34 - $9.15 $780,836 - $973,386	106,381 Added 416.51%	131,922 $1.12 Million
Q4 2022 Feb 14, 2023	BUY	$7.79 - $8.98 $198,964 - $229,358	25,541 New	25,541 $221,000
Q4 2021 Feb 14, 2022	SELL	$2.83 - $7.26 $1.54 Million - $3.95 Million	-544,706 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.7 - $11.54 $444,665 - $765,886	-66,368 Reduced 10.86%	544,706 $4.21 Million
Q2 2021 Aug 16, 2021	BUY	$11.66 - $24.23 $7.13 Million - $14.8 Million	611,074 New	611,074 $7.13 Million

Others Institutions Holding VECT

# of Institutions

1

Shares Held

510K

Call Options Held

0

Put Options Held

0

Regency Capital Management Inc.\De

510K
Shares

$0
0.0% of portfolio

About VectivBio Holding AG

Ticker VECT
Exchange NASDAQ
Description
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with sho...

More about VECT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.